Evidence map›Paper›PMID 31417401›Full record

ReviewFrontiers in pharmacology2019

Natural Plants Compounds as Modulators of Epithelial-to-Mesenchymal Transition.

Lorena Avila-Carrasco, Pedro Majano, José Antonio Sánchez-Toméro, Rafael Selgas, Manuel López-Cabrera, Abelardo Aguilera, Guadalupe González Mateo

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 1 synthesis or guideline pooled it, 204 citations in OpenAlex.

  1. Pooled it
  2. Advances in sirtuin research in lung diseases (Review).International journal of molecular medicine · 2026
    Review
  3. Review
  4. Antimetastatic Effects of aAntioxidants (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Lorena Avila-CarrascoTherapeutic and Pharmacology Department, Health and Human Science Research, Academic Unit of Human Medicine and Health Sciences, Autonomous University of Zacatecas, Zacatecas, Mexico.
Pedro MajanoMolecular Biology Unit, Research Institute of University Hospital La Princesa (IP), Madrid, Spain.
José Antonio Sánchez-ToméroDepartment and Nephrology, Research Institute of University Hospital La Princesa (IP), Madrid, Spain.
Rafael SelgasResearch Institute of La Paz (IdiPAZ), University Hospital La Paz, Madrid, Spain.
Manuel López-CabreraRenal research network REDINREN, Madrid, Spain.
Abelardo AguileraMolecular Biology Unit, Research Institute of University Hospital La Princesa (IP), Madrid, Spain.
Guadalupe González MateoResearch Institute of La Paz (IdiPAZ), University Hospital La Paz, Madrid, Spain.
Spanish Clinical Research Network · ESHospital Universitario de La Princesa · ESHospital La Paz Institute for Health Research · ESUniversidad Autónoma de Zacatecas "Francisco García Salinas" · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial-to-mesenchymal transition (EMT) is a self-regulated physiological process required for tissue repair that, in non-controled conditions may lead to fibrosis, angiogenesis, loss of normal organ function or cancer. Although several molecular pathways involved in EMT regulation have been described, this process does not have any specific treatment. This article introduces a systematic review of effective natural plant compounds and their extract that modulates the pathological EMT or its deleterious effects, through acting on different cellular signal transduction pathways both

Indexed as

anti-fibroticanti-inflammatoryanti-oxidant agentepithelial-to-mesenchymal transition (EMT)natural plants compounds

Identifiers

PMID31417401
PMCPMC6682706
OpenAlexW2965216369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.